Drugs, sex . . . and alcohol? Extending the community pharmacist's public health role

M. C. Watson,J. Sheridan

DOI: https://doi.org/10.1111/j.2042-7174.2011.00138.x

2011-08-01

International Journal of Pharmacy Practice

Abstract:There is growing recognition of the community pharmacist’s role as a public health practitioner. This has developed from their traditional function as medicine supplier (ideally, to achieve safe and effective medicine use), to their now wellestablished roles in public health. Community pharmacy has been particularly responsive to public health initiatives in the area of substance misuse and sexual health. In addition to smoking-cessation interventions, and in response to a potential HIV/AIDS epidemic in the 1980s, community pharmacy took on board the delivery of needle-exchange services and opioid-substitution therapy (methadone) as part of a manyfaceted, and ultimately successful, attempt to prevent the spread of HIV. More recently we have seen developments in the community pharmacist’s role in Chlamydia screening and treatment, the provision of emergency hormonal contraception, and testing for hepatitis. The extent to which these services are evidence-based is variable, sometimes informed by the results of randomised controlled trials and systematic reviews (e.g. smokingcessation services), but more often evaluated using smallscale, uncontrolled studies (e.g. Chlamydia testing services). The availability of rigorously derived evidence not only supports the pharmacy profession in the development of the public health role, but also plays an important part in justifying ongoing contractual arrangements and financial support for pharmacists. Furthermore, the evidence is often lacking in terms of the optimal delivery of these services. Attention has now turned to the potential role of community pharmacists (and their staff) in the identification of harmful and hazardous alcohol consumption and the delivery of interventions to address this problem. Alcohol misuse is a major and growing public health concern as it is associated with substantial mortality and morbidity. It also incurs vast costs to society, not solely in terms of health, but also due to social work, criminal justice and emergency services involvement, and general human costs (e.g. employment or relationship problems). Scotland has one of the highest levels of national alcohol consumption worldwide. As a response to this problem, the Scottish Intercollegiate Guidelines Network (SIGN), Guideline 74, was developed and refers to the management of harmful drinking and alcohol dependence in primary care. The guideline recommends that ‘primary care health professionals should opportunistically identify hazardous and harmful drinks and deliver a brief (10 min) intervention’. Hazardous drinking is the regular consumption of more than the recommended upper limit of alcohol. Harmful drinking is ‘a pattern of drinking that causes damage to physical health (e.g. liver) or mental health (e.g. episodes of depression secondary to heavy consumption of alcohol)’. Screening, followed by brief interventions, is effective in reducing alcohol consumption and can be delivered in primary care. A brief intervention is an intervention which may last from 5 to 45 min, which may include the use of a protocol or guidelines to provide a specific service. In general, in primary care, alcohol brief interventions (ABIs) consist of screening to identify individuals who would benefit from intervention; such interventions are commonly a short verbal/counselling session of 5–10 min, written information to take away, and occasionally a diary to record alcohol intake. Although there is a strong theoretical basis to brief interventions and substantial evidence of their effect in achieving reduced alcohol consumption when delivered by non-pharmacy, primary care practitioners, there is limited evidence of their effectiveness and cost-effectiveness in the community pharmacy setting. A systematic review identified three proof-of-concept studies, all of which were conducted in the UK, that evaluated community pharmacy-based alcohol-misuse services provided through 14 pharmacies to around 500 customers. Two of these studies reported nonsignificant reductions in alcohol consumption following brief interventions by pharmacists. The proportion of pharmacy customers identified as having hazardous or harmful drinking behaviour ranged from 30 to 53%. Whereas these proof-of-concept studies provide useful data regarding the Editorial